madhur ka chart Ansaco 400mg/800mg approved for entry into China Kintor Pharmaceuticals launches Phase II clinical trial of "Furetan Tincture" Guangdong officially reports volume for the third batch ...

The Book Of Hor pdf R&D Daily丨Hengrui Submits Two New Indications for PD-1 for Marketing Approval Alphamab Oncology's PD-L1/CTLA-4 dual antibody KN046 received approval for Phase II clinical trial ...

During services on December 21 and 22, St. Martin’s Lutheran Church and School announced plans for a capital fundraising campaign. The campaign theme is “Continuing the Mission.” Its aim is ...

To pave or not to pave. Though seemingly settled, the debate continues whether to pave a section of the proposed Phase II of ...

Sales of PBYI's sole-marketed drug, Nerlynx exceeded management's expectations in the third quarter. Also, the acquisition of alisertib holds promise.

Alpelisib, we ran into a lot of toxicities, but they were all alpelisib toxicities. So a lower dose will be tested in the next cohort with elacestrant. And then capivasertib [Truqap] is in the early ...

Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

Max Estates COO Rishi Raj said the company is confident of adding 'at least 3 million sq. ft. every year' to the current portfolio, and diversifying in Delhi NCR across commercial and residential ...